FI933872A - Foerfarande foer framstaellning av terapeutiskt anvaendbara 1,3,4-bensotriazepin-5(4H)-on-derivat - Google Patents

Foerfarande foer framstaellning av terapeutiskt anvaendbara 1,3,4-bensotriazepin-5(4H)-on-derivat Download PDF

Info

Publication number
FI933872A
FI933872A FI933872A FI933872A FI933872A FI 933872 A FI933872 A FI 933872A FI 933872 A FI933872 A FI 933872A FI 933872 A FI933872 A FI 933872A FI 933872 A FI933872 A FI 933872A
Authority
FI
Finland
Prior art keywords
benzotriazepine
derivatives
preparation
active substances
therapeutically active
Prior art date
Application number
FI933872A
Other languages
English (en)
Finnish (fi)
Other versions
FI933872A0 (fi
Inventor
Ilona Bodi
Eva Gal
Melinda Gal
Laszlo Jaszlits
Andrea Jednakovits
Adrina Kiss
Nee Kovacs Aniko Miklos
Gyoergy Mathe
Istvan Pallagi
Gyoergy Rabloczky
Antal SIMAI
Endre Tihanyi
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of FI933872A0 publication Critical patent/FI933872A0/fi
Publication of FI933872A publication Critical patent/FI933872A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D255/00Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00
    • C07D255/04Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00 condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI933872A 1992-09-04 1993-09-03 Foerfarande foer framstaellning av terapeutiskt anvaendbara 1,3,4-bensotriazepin-5(4H)-on-derivat FI933872A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9202833A HU212266B (en) 1992-09-04 1992-09-04 Process for producing novel 1,3,4-benzotriazepin-5(4h)-one derivatives and pharmaceutical preparations containing them

Publications (2)

Publication Number Publication Date
FI933872A0 FI933872A0 (fi) 1993-09-03
FI933872A true FI933872A (fi) 1994-03-05

Family

ID=10982296

Family Applications (1)

Application Number Title Priority Date Filing Date
FI933872A FI933872A (fi) 1992-09-04 1993-09-03 Foerfarande foer framstaellning av terapeutiskt anvaendbara 1,3,4-bensotriazepin-5(4H)-on-derivat

Country Status (14)

Country Link
US (1) US5441948A (fr)
JP (1) JPH06157483A (fr)
KR (1) KR940007008A (fr)
CN (1) CN1087632A (fr)
CH (1) CH686081A5 (fr)
CZ (1) CZ182493A3 (fr)
DE (1) DE4329874A1 (fr)
FI (1) FI933872A (fr)
FR (1) FR2695388B1 (fr)
GB (1) GB2270313B (fr)
HU (1) HU212266B (fr)
IT (1) IT1273981B (fr)
NL (1) NL9301524A (fr)
YU (1) YU58093A (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104961747B (zh) * 2015-06-02 2017-10-24 大连理工大学 一种四氢苯并[d][1,2,6]氧杂二氮*类化合物及其制备方法
CN104945403B (zh) * 2015-06-02 2017-07-21 大连理工大学 一种四氢苯并[e][1,2,4]三氮杂*类化合物及其制备方法
CN105037386B (zh) * 2015-06-02 2017-10-24 大连理工大学 一种四氢苯并[c][1,2,5]噁二嗪类化合物及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57109772A (en) * 1980-12-27 1982-07-08 Otsuka Pharmaceut Co Ltd Benzotriazepine derivative
US4482547A (en) * 1982-08-26 1984-11-13 Hoechst-Roussel Pharmaceuticals Inc. Substituted-1,3,4-benzotriazepines

Also Published As

Publication number Publication date
FI933872A0 (fi) 1993-09-03
HU212266B (en) 1996-04-29
GB2270313B (en) 1995-07-12
CZ182493A3 (en) 1994-04-13
US5441948A (en) 1995-08-15
ITMI931897A0 (it) 1993-09-03
CN1087632A (zh) 1994-06-08
HU9202833D0 (en) 1992-11-30
IT1273981B (it) 1997-07-14
KR940007008A (ko) 1994-04-26
FR2695388A1 (fr) 1994-03-11
GB2270313A (en) 1994-03-09
CH686081A5 (de) 1995-12-29
YU58093A (sh) 1996-02-19
NL9301524A (nl) 1994-04-05
DE4329874A1 (de) 1994-03-10
JPH06157483A (ja) 1994-06-03
ITMI931897A1 (it) 1995-03-03
FR2695388B1 (fr) 1995-05-24
HUT67062A (en) 1995-01-30
GB9318254D0 (en) 1993-10-20

Similar Documents

Publication Publication Date Title
NO904694D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater.
NO901684D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater.
NO903088D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive diazepin-derivater.
NO914667L (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylderivater
NO894630D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater.
NO914036D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater
NO904986L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive diazepin-derivater.
NO893616L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tricykliske forbindelser.
NO900032L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazol-forbindelser.
NO903941D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive diazepinon-derivater.
NO890155D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive indolpiperidin-forbindelser.
NO900697D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive acetamid-derivater.
NO891723L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO895220D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzenderivater.
NO865012L (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzazepin-derivater.
FI933872A (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 1,3,4-bensotriazepin-5(4H)-on-derivat
NO913187D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tricykliske derivater.
NO900972D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive naftalen-derivater.
NO893768L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 2,7-diamino-1,2,3,4-tetrahydronaftalenderivater.
NO167801C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,2'-bi-1h-imidazolderivater.
NO900942D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive azacyklooktadien-derivater.
NO890724D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetraazaacenaftylen-derivater.
NO904470D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzodiazepinderivater.
NO890519D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive propanon-derivater.
NO890506D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kloranilin-derivater.

Legal Events

Date Code Title Description
FD Application lapsed